Provid Pharmaceuticals

Developing MHC inhibition drugs for multiple sclerosis and autoimmune diseases

placeMonmouth Junction, New Jersey, United States calendar_todayFounded 2001 groups5 employees language provid.com

Registered entities

Innovation

10 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 674 times.

YearFilings
20143
20154
20166
20175
20184
20192
20202
20212
20224
20233
20243
20253

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon